Over the last 12 months, Cellebrite DI insiders reported no purchases and 3 sales totaling $2.3M across SEC Form 4 filings. 33% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Barter DavidChief Financial Officer · O | ▼ Sale | 41,734 | $16.38 | $683K | -11.1% | — |
| Jul 2, 2026 | Hogan Thomas E.Chief Executive Officer · O·D | ▼ Sale | 103,188 | $15.76 | $1.6M | -14.9% | — |
| May 21, 2026 | GEE DAVID NICHOLASChief Marketing Officer · O | ▼ Sale | 2,243 | $13.1 | $29K | -1.5% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CLBT feed.